on 29 May 2014
Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Company on 29 May 2014 to consider and approve the audited financial results of the Company stand alone and consolidated for the year ended 31 March 2014. The said audited results are subject to revision so as to give effect of demerger with effect from 01 May 2013 of the Specified Undertaking of Sun Pharma Global FZE, the Company's wholly owned subsidiary company with the Company, after receipt of all required approvals from the statutory authorities in respect of the demerger.Powered by Capital Market - Live News
